Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-23

Clinical Trial Update: The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial update evaluating the efficacy and safety of chloroprocaine 1% and 2% in children; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroprocaine (Chloroprocaine)

Snippet

Sponsor: Sintetica SA | Conditions: Hernia, Inguinal, Flat Foot | Phase 2 | Status: COMPLETED